Neutropenia, a common phenomenon during chemotherapy, seriously affects the therapeutic effect and patient prognosis, and clinicians usually use recombinant G‐CSF or GM‐CSF to induce neutropenia to increase patients’ white blood cell counts and enhance their immunity during chemotherapy in cancer patients [225]. The gene discussed is CSF3; the disease is neutropenia.